Stem cell collection considerations for AL amyloidosis

Eric A. Gehrie, Garrett S. Booth

Research output: Contribution to journalArticlepeer-review

Abstract

Amyloidosis is a progressive disease that traditionally is associated with poor clinical outcomes. Recent advances in amyloidosis treatment may allow for more patients tobe considered for autologous stem cell transplantation. In this report, we review a case of autologous peripheral blood stem cell transplantation in a patient with systemic amyloidosis and review special considerations in peripheral blood stem cell collection in such patients. We conclude that it may be reasonable to consider substituting heparin for some of the citrate used in peripheral blood stem cell collection procedures performed on patients with cardiac amyloidosis, so long as there are no contraindications to heparin exposure.

Original languageEnglish (US)
Pages (from-to)587-590
Number of pages4
JournalConnecticut medicine
Volume78
Issue number10
StatePublished - Jan 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Stem cell collection considerations for AL amyloidosis'. Together they form a unique fingerprint.

Cite this